Composition and method for reducing blood glucose levels
View Patent ↗The present invention relates to a composition and method for reducing blood glucose levels in a mammal, such as canines and humans. The composition includes bran, cinnamon, yeast, gelatin, and optionally, wheat germ oil, octacosanol, and/or flavor. The method includes administering the composition to the mammal and, if the composition lacks wheat germ oil, also administering wheat germ oil to the mammal.
1. A method of reducing a blood glucose level in a canine subject in need thereof, the method comprising administering to the subject a composition comprising:
about 10 to about 45 wt-% yeast;
about 10 to about 70 wt-% bran;
about 2 to about 30 wt-% cinnamon; and
about 5 to about 15 wt-% gelatin;
wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels.
2. The method of claim 1 , wherein the subject also receives insulin to control the blood glucose level.
3. The method of claim 2 , comprising administering the composition within one hour after the subject receives a dose of insulin.
4. The method of claim 1 , comprising administering the composition within one hour before a meal.
5. The method of claim 1 , wherein the composition further comprises an ingredient selected from the group consisting of:
about 5 to about 15 wt-% wheat germ oil;
about 5 to about 30 wt-% flavoring;
about 0.1 to about 2 wt-% octacosanol;
about 0.5 to about 3 wt-% chromium enhanced yeast; and
a mixture thereof.
6. The method of claim 1 , wherein:
the bran comprises approximately equal amounts of wheat bran and oat bran.
7. The method of claim 1 , wherein the composition comprises:
about 22 wt-% brewers yeast;
about 44 wt-% bran;
about 11 wt-% cinnamon;
about 11 wt-% gelatin; and
further comprises about 11 wt-% wheat germ oil.
8. The method of claim 1 , wherein the composition comprises:
about 17 wt-% brewers yeast;
about 34 wt-% bran;
about 9 wt-% cinnamon;
about 9 wt-% gelatin; and
further comprises:
about 9 wt-% wheat germ oil;
about 17 wt-% flavoring; and
about 0.7 wt-% octacosanol.
9. The method of claim 1 , wherein the composition comprises:
about 33 wt-% brewers yeast;
about 38 wt-% bran;
about 19 wt-% cinnamon;
about 9 wt-% gelatin; and
further comprises about 1.6 wt-% chromium enhanced yeast.
10. A method of reducing a blood glucose level in a canine subject in need thereof, the method comprising administering to the subject a composition comprising:
about 17 wt-% brewers yeast;
about 34 wt-% bran;
about 9 wt-% cinnamon;
about 9 wt-% gelatin;
about 9 wt-% wheat germ oil;
about 17 wt-% flavoring; and
about 0.7 wt-% octacosanol;
wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels.
11. A method of reducing a blood glucose level in a canine subject in need thereof, the method comprising administering to the subject a composition comprising:
about 33 wt-% brewers yeast;
about 38 wt-% bran;
about 19 wt-% cinnamon;
about 9 wt-% gelatin; and
about 1.6 wt-% chromium enhanced yeast;
wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels.
12. The method of claim 1 , wherein the yeast is selected from the group consisting of brewers yeast, chromium enhanced yeast, and a mixture thereof.
13. The method of claim 1 , wherein:
the bran comprises approximately equal amounts of wheat bran and oat bran; and
the yeast is selected from the group consisting of brewers yeast, chromium enhanced yeast, and a mixture thereof.